The role of c-erbB-2 expression on the survival of patients with small-cell lung cancer

Lung

Volumn 184, Issue 5, 2006, Pages 267-272

  Canoz, Ozlem ^a,b   Ozkan, Metin ^b   Arsav, Vedat ^b   Er, Ozlem ^b   Coskun, H Senol ^c   Soyuer, Serdar ^b   Altinbas, Mustafa ^b  

^a Medical Faculty ^*  (Turkey)

^b ERCIYES UNIVERSITY   (Turkey)

^c SULEYMAN DEMIREL UNIVERSITY   (Turkey)

Author keywords

c erbB 2; Prognosis; Small cell lung careinoma

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIRUBICIN; ETOPOSIDE; PARAFFIN; VINCRISTINE;

ADULT; ARTICLE; CANCER SURVIVAL; CLINICAL STUDY; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOTHERAPY; LUNG PARENCHYMA; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; SURVIVAL RATE;

ADULT; AGED; BIOPSY; BRONCHOSCOPY; CARCINOMA, SMALL CELL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MIDDLE AGED; RECEPTOR, ERBB-2; RETROSPECTIVE STUDIES; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL; TURKEY;

EID: 33846450717     PISSN: 03412040     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00408-005-2591-y     Document Type: Article

References (26)

1. Artega CL (1995) Epidermal growth factor receptors and c-erbB-2 in human lung cancer. In: Pass HI, Mitchell JB, Johnson DH, Turrisi AT (eds) Lung Cancer. Principles and practice. Lippincott, Philadelphia, pp 107-121
2. Coombs LM, Pigott DA, Sweeney E, et al. (1991) Amplification and over-expression of c-erbB-2 in transitional cell carcinoma of the urinary bladder. Br J Cancer 63:601-608
3. Elias AD (1997) Small cell lung cancer: state-of-the-art therapy in 1996. Chest 12:251s-258s
4. Fu XL, Zhu XZ, Wang LJ, et al. (1999) Study of prognostic predictors for non-small cell lung cancer. Lung Cancer 23:143-152
5. Giatromanolaki A, Koukourakis MI, O'Byrne K, et al. (1996) Non-small cell lung cancer: c-erbB-2 overexpression correlates with low angiogenesis and poor prognosis, Anticancer Res l6:3819-3825
6. Hall PA, Hughes CM, Staddon SL, et al. (1990) The c-erbB-2 proto-oncogene in human pancreatic cancer. J Pathol 161:195-200
7. Han H, Lanreneu RJ, et al. (2002) Prognostic value of immunohistochemical expression of p53, HER2/neu, and bcl-2 in stage I non-small cell lung cancer. Hum Pathol 33:105-110
8. Hanna W, Kahn HJ, Trudeau M (1999) Evaluation of Her-2/neu (erbB-2) status in breast cancer: From bench to bedside. Mod Pathol 12:827-834
9. Hirashima N, Takahashi W, Yoshii S, Yamane T, Ooi A (2001) Protein overexpression and gene amplification of c-erbB-2 in pulmonary carcinomas: a comparative immunohistochemical and fluorescence in situ hybridization study. Mod Pathol 14:556-562
10. Ihde DC (1992) Chemotherapy of lung cancer. N EngI J Med 327:1434-l441
11. Kay EW, Mulcahy H, Walsh CB, Leader M, O'Donoghue D (1994) Cytoplasmic c-erbB-2 protein expression correlates with survival in Duke' a post B colorectal carcinoma. Histopathology 25:455-461
12. Landis SH, Murray T, Bolden S, Wingo PA (1998) Cancer statistics, 1998. CA Cancer J Clin 48:6-29
13. Micke P, Hengstler JG, Ros R, et al. (2001) c-erbB-2 expression in small-cell lung cancer is associated with poor prognosis. Int J Cancer 92:474-479
14. Peethambaram PP, Cliby WA, Lubiniecki G, et al. (2003) HER2/neu expression in ovarian cancer: Pre and postexposure to platinum chemotherapy. Gynecol Oncol 89:99-104
15. Pfeiffer P, Clausen PP, Andersen K, Rose C (1996) Lack of prognostic significance of epidermal growth factor receptor and the oncoprotein p185HER2 in patients with systemically untreated non-small-cell lung cancer: an immunohistochemical study on cryosections. Br J Cancer 74:86-91
16. Saad RS, Liu Y, Han H, Landreneau RJ, Silverman JF (2004) Prognostic significance of HER2/neu, p53, and vascular endothelial growth factor expression in early stage conventional adenocarcinoma and bronchioloalveolar carcinoma of the lung. Mod Pathol 17:1235-1242
17. Schechter AL, Stem DF, Vaidyanathan L, et al. (1984) The neu oncogene encode: An erbB related gen encoding a 185,000-Mr tumour antigen. Nature 312:513-516
18. Schneider PM, Hung MC, Chiocca SM, et al. (1989) Differential expression of the c-erbB-2 gene in human small cell and non-small cell lung cancer. Cancer Res 49:4968-4971
19. Shiraishi M, Noguchi M, Shimosato Y, Sekiya T (1989) Amplification of protooncogenes in surgical specimens of human lung carcinomas. Cancer Res 49:6474-6479
20. Slamon DJ, Leyland-Jones B, Shak S, et al. (2001) Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl J Med 344:783-792
21. Sloman A, D'Amco F, Yousem SA (1996) Immunohistochemical markers of prolonged survival in small cell carcinoma of the lung. An immunohistochemical study. Arch Pathol Lab Med 120:465-472
22. Stahel RA, Ginsberg R, Havemann K (1989) Staging and prognostic factors in small cell lung cancer: a consensus report. Lung Cancer 5:119-126
23. Sugg SL, Ezzat S, Zheng L, et al. (1998) Cytoplasmic staining of erbB-2 but not mRNA levels correlates with differentiation in human thyroid neoplasia. Clin Endocrinol (Oxf) 49:629-637
24. Tetu B, Brisson J (1994) Prognostic significance of HER-2/neu oncoprotein & expression in node positive breast cancer. The influence of the pattern of immunostaining and adjuvant therapy. Cancer 73:2359-2365
25. Treish I, Schwartz R, Lindley C (2000) Pharmacology and therapeutic use of trastuzumab in breast cancer. Am J Health Syst Pharm 57:2063-2076
26. Weiner DB, Nordberg J, Robinson R (1990) Expression of the neu gene-encoded protein (P185neu) in human non-small cell carcinomas of the lung. Cancer Res 50:421-425